About
Profile
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
JNJ
The healthcare conglomerate saw shares rising slightly premarket after quarterly results exceeded expectations on the back of strong sales of oncology drugs. J&J also raised forward financial guidance for full-year 2024 profit and sales.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform
- Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M
- J&J looks to continue long streak of EPS beats with Q2 results
- J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)
- J&J becomes latest Big Pharma to sue over Medicare drug pricing
- Nanobiotix partners with J&J's Janssen for radiotherapy treatment
- Atrial fibrillation drug market expected to decline as brand therapies go generic
- Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
- Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
- FDA classifies J&J electrode recall as most serious type
- Goldman Sachs sees rays of hope in underperforming health sector
- Bausch + Lomb buys Blink eye drops from Johnson & Johnson
- Johnson & Johnson psoriasis pill disappoints in phase 2 trial
- Medicare revises guidance on drug price negotiations amid lawsuits
- Morgan Stanley shakes up its global dividend portfolio
- J&J submits application to EMA for combination PAH drug
- What is behind big pharma's underperformance?
- J&J talc bankruptcy unit to establish $750M trust fund with insurers
- Cidara gains as FDA grants fast track status for flu candidate
- Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| January 25, 2022 | 2.13 / 2.12 | 24.8B / 25.28B | |
| October 19, 2021 | 2.6 / 2.35 | 23.34B / 23.64B | |
| July 21, 2021 | 2.48 / 2.29 | 23.31B / 22.49B |
Beat! |
| April 20, 2021 | 2.59 / 2.34 | 22.32B / 21.98B |
Beat! |
| January 26, 2021 | 1.86 / 1.82 | 22.48B / 21.66B |
Beat! |
| October 13, 2020 | 2.2 / 1.98 | 21.08B / 20.2B |
Beat! |
| July 16, 2020 | 1.67 / 1.49 | 18.34B / 17.61B |
Beat! |
| April 14, 2020 | 2.3 / 2.02 | 20.69B / 19.73B |
Beat! |
| January 22, 2020 | 1.88 / 1.87 | 20.75B / 20.8B | |
| October 15, 2019 | 2.12 / 2.01 | 20.73B / 20.08B |
Beat! |
| July 16, 2019 | 2.58 / 2.46 | 20.56B / 20.29B |
Beat! |
| April 16, 2019 | 2.1 / 2.04 | 20.02B / 19.61B |
Beat! |
| January 22, 2019 | 1.97 / 1.95 | 20.39B / 20.2B |
Beat! |
| October 16, 2018 | 2.05 / 2.03 | 20.35B / 20.05B |
Beat! |
| July 17, 2018 | 2.1 / 2.07 | 20.83B / 20.42B |
Beat! |
| April 17, 2018 | 2.06 / 2 | 20.01B / 19.49B |
Beat! |
| January 23, 2018 | 1.74 / 1.72 | 20.2B / 20,072M | |
| October 17, 2017 | 1.9 / 1.80 | 19.65B / 19,283M | |
| July 18, 2017 | 1.83 / 1.80 | 18.84B / 18,935M | |
| April 18, 2017 | 1.83 / 1.77 | 17.77B / 18,037M |
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Nov 20 | 153.11 | 153.03 |
153.25
|
151.82
|
6.7M | 0.07% | |||
| Nov 19 | 153 | 153.95 |
153.99
|
152.05
|
8.2M | -1.14% | |||
| Nov 18 | 154.77 | 152.59 |
155.33
|
152.33
|
7.5M | 0.50% | |||
| Nov 15 | 154 | 150.9 |
154.43
|
150.9
|
11.3M | 1.40% | |||
| Nov 14 | 151.87 | 153.18 |
153.59
|
150.76
|
7.7M | -0.89% | |||
| Nov 13 | 153.24 | 152.5 |
153.51
|
151.42
|
7.2M | 0.39% | |||
| Nov 12 | 152.64 | 154.53 |
155.04
|
152.37
|
7.2M | -1.55% | |||
| Nov 11 | 155.04 | 155.62 |
157.58
|
154.91
|
7.1M | -0.28% | |||
| Nov 8 | 155.47 | 157 |
157.08
|
155.41
|
8.9M | -0.8% | |||
| Nov 7 | 156.73 | 158.47 |
158.75
|
156.51
|
7.5M | -0.73% | |||
| Nov 6 | 157.88 | 159.9 |
160.85
|
157.35
|
8.9M | -0.3% | |||
| Nov 5 | 158.35 | 157.67 |
158.59
|
156.35
|
6.5M | 0.07% | |||
| Nov 4 | 158.24 | 159.7 |
160.28
|
158.07
|
4.6M | -1.18% | |||
| Nov 1 | 160.13 | 160.58 |
161.06
|
159.88
|
5.3M | 0.17% | |||
| Oct 31 | 159.86 | 159.99 |
160.87
|
159.46
|
8.6M | -0.47% | |||
| Oct 30 | 160.61 | 159.45 |
161.28
|
159.03
|
5.8M | 0.32% | |||
| Oct 29 | 160.09 | 161.46 |
162.17
|
160.06
|
5.2M | -0.93% | |||
| Oct 28 | 161.6 | 161.13 |
161.97
|
161
|
4.8M | 0.45% | |||
| Oct 25 | 160.88 | 163.68 |
163.92
|
160.61
|
6.4M | -1.7% | |||
| Oct 24 | 163.67 | 165 |
165.51
|
163.34
|
5.4M | -1.32% | |||
| Oct 23 | 165.86 | 162.82 |
166
|
162.42
|
7.4M | 1.47% | |||
| Oct 22 | 163.45 | 162.32 |
163.73
|
161.9
|
5.7M | 0.38% | |||
| Oct 21 | 162.83 | 165.1 |
165.25
|
162.31
|
6.1M | -1.39% | |||
| Oct 18 | 165.12 | 164.89 |
165.29
|
163.93
|
5.9M | 0.40% | |||
| Oct 17 | 164.47 | 164.26 |
165
|
163.63
|
4.8M | 0.12% | |||
| Oct 16 | 164.28 | 164 |
164.99
|
162.64
|
6.0M | 0.11% | |||
| Oct 15 | 164.1 | 160 |
166.75
|
159
|
10.5M | 1.55% | |||
| Oct 14 | 161.6 | 161.4 |
162.14
|
160.9
|
6.0M | 0.09% | |||
| Oct 11 | 161.46 | 162.18 |
162.66
|
161.2
|
5.3M | 0.59% | |||
| Oct 10 | 160.51 | 161.36 |
161.39
|
159.99
|
4.8M | -0.09% | |||
| Oct 9 | 160.65 | 159.92 |
161.21
|
159.51
|
6.0M | 0.60% | |||
| Oct 8 | 159.69 | 159.49 |
160.24
|
158.95
|
4.8M | 0.10% | |||
| Oct 7 | 159.53 | 160.25 |
160.86
|
159.22
|
4.3M | -0.47% | |||
| Oct 4 | 160.29 | 159.63 |
160.5
|
158.77
|
5.3M | -0.13% | |||
| Oct 3 | 160.5 | 160.78 |
161.44
|
160.22
|
4.8M | -0.42% | |||
| Oct 2 | 161.17 | 161.51 |
162.12
|
160.65
|
4.7M | -0.51% | |||
| Oct 1 | 161.99 | 162.43 |
162.75
|
161.18
|
4.4M | -0.04% | |||
| Sep 30 | 162.06 | 161.57 |
162.18
|
160.68
|
6.0M | 0.41% | |||
| Sep 27 | 161.4 | 162 |
163.43
|
161.34
|
7.6M | 0.01% | |||
| Sep 26 | 161.39 | 160.24 |
161.54
|
160.02
|
6.1M | 0.49% | |||
| Sep 25 | 160.6 | 163 |
163.32
|
160.36
|
5.4M | -1.34% | |||
| Sep 24 | 162.78 | 162.79 |
163.49
|
161.55
|
6.0M | -0.27% | |||
| Sep 23 | 163.22 | 164.4 |
164.5
|
162.72
|
4.7M | -0.57% | |||
| Sep 20 | 164.16 | 164.3 |
164.87
|
163.55
|
11.8M | -0.4% | |||
| Sep 19 | 164.82 | 166.23 |
166.37
|
164.42
|
5.0M | -0.8% | |||
| Sep 18 | 166.15 | 166.63 |
168.35
|
165.74
|
4.7M | -0.55% | |||
| Sep 17 | 167.07 | 166.24 |
167.72
|
165.93
|
5.1M | 0.05% | |||
| Sep 16 | 166.99 | 166.36 |
167.25
|
165.78
|
5.2M | 0.89% | |||
| Sep 13 | 165.52 | 164.74 |
165.75
|
163.82
|
3.7M | 0.53% | |||
| Sep 12 | 164.64 | 164.2 |
165.1
|
162.71
|
4.5M | -0.11% | |||
| Sep 11 | 164.82 | 166.79 |
166.79
|
164.09
|
5.9M | -1.53% | |||
| Sep 10 | 167.38 | 167.5 |
168.46
|
166.74
|
6.6M | 0.46% | |||
| Sep 9 | 166.61 | 164.84 |
167.4
|
164.47
|
7.5M | 1.36% | |||
| Sep 6 | 164.38 | 165.18 |
165.94
|
164.12
|
6.0M | -0.37% | |||
| Sep 5 | 164.99 | 167.2 |
167.37
|
164.83
|
4.6M | -1.42% | |||
| Sep 4 | 167.36 | 167.81 |
168.85
|
166.04
|
6.9M | 0.12% | |||
| Sep 3 | 167.16 | 165.24 |
167.81
|
164.77
|
7.0M | 0.78% | |||
| Aug 30 | 165.86 | 164.12 |
165.98
|
163.81
|
8.0M | 0.99% | |||
| Aug 29 | 164.23 | 164.63 |
164.72
|
163.36
|
7.4M | 0.19% | |||
| Aug 28 | 163.92 | 163 |
165
|
162.71
|
5.2M | 0% | |||